Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 331 followers
Latest posts
Last updated about 11 hours ago
Human medicines European public assessment report (EPAR): Mekinist, trametinib, Date of authorisation: 30/06/2014, Revision: 39, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Mekinist, trametinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Date of authorisation: 29/03/2009, Revision: 37, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine...
Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 18, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of...
Product-specific bioequivalence guidance
about 12 hours ago
Product-specific bioequivalence guidance
Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (27 March 2026 - 23 April 2026)
about 12 hours ago
Start of procedure: Type II Variation - Extension of indication under evaluation...
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 41, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of...
Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 23, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of...
Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Date of authorisation: 27/04/2026, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 40, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation...
Agenda of the CVMP meeting 19-21 May 2026
about 14 hours ago
Agenda of the CVMP meeting 19-21 May 2026
Presentation - CTIS Bitesize Talk: End of transition period and notifications including serious breaches
about 15 hours ago
Presentation - CTIS Bitesize Talk: End of transition period and notifications including...
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 10, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation...